Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by Syndicate of Premier Healthcare Investors
August 9, 2023
Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, on its private placement financing of up to $150 million.
Laekna Announces Largest 18A IPO Year to Date at HK$791 Million
June 29, 2023
Cooley advised China International Capital Corporation Hong Kong Securities Limited (CICC) and other underwriters on Laekna’s HK$791 million (US$101 million) initial public offering of 63,728,000 shares on the Hong Kong Stock Exchange, the largest 18A offering year to date.